ASBPW

Aspire Biopharma Holdings, Inc. Warrant

40 hedge funds and large institutions have $1.15M invested in Aspire Biopharma Holdings, Inc. Warrant in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
+5
Holders Change %
+14.29%
% of All Funds
0.63%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
3
Reduced
3
Closed
2
Calls
$2.12M
Puts
Net Calls
+$2.12M
Net Calls Change
+$5K
Name Holding Trade Value Shares
Change
Shares
Change %
MP
1
Mangrove Partners
Connecticut
$652K
PC
2
Periscope Capital
Ontario, Canada
$73.2K +$1.25K +25,000 +2%
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$52.6K
LA
4
Linden Advisors
New York
$49.5K
SCM
5
Saba Capital Management
New York
$49.3K
AA
6
AQR Arbitrage
Connecticut
$32.4K -$181 -3,612 -0.6%
SC
7
Sculptor Capital
New York
$27.5K
Verition Fund Management
8
Verition Fund Management
Connecticut
$21.7K
WAM
9
Wolverine Asset Management
Illinois
$20.1K
SFM
10
Spartan Fund Management
Canada
$18.7K +$179 +1,804 +1%
Barclays
11
Barclays
United Kingdom
$18K
KC
12
Kepos Capital
New York
$18K +$18K +350,000 New
TCA
13
Taconic Capital Advisors
New York
$15K
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$10K
RCM
15
Radcliffe Capital Management
Pennsylvania
$9K
CCM
16
Context Capital Management
California
$9K
SRCM
17
Sage Rock Capital Management
New York
$8.02K
Nomura Holdings
18
Nomura Holdings
Japan
$7.5K
PAMP
19
Polar Asset Management Partners
Ontario, Canada
$6.94K
LP
20
LMR Partners
United Kingdom
$6.26K
WA
21
Whitebox Advisors
Minnesota
$6.26K
HIM
22
HGC Investment Management
Ontario, Canada
$6K +$6K +100,000 New
KL
23
KIM LLC
Kansas
$5.5K
HCM
24
Highbridge Capital Management
New York
$4.6K -$4K
CCM
25
CAAS Capital Management
New York
$3.76K